Great to see @greg-wells.bsky.social and @ljtl.bsky.social on behalf of the Sheffield ex vivo group. Well done!

Longer hours. But why? #PhDchat #PhDforum #ECRchat #postdoc

PREPRINT CLAIMING LINK BETWEEN mRNA VACCINES A D CANCER HAS BEEN WITHDRAWN. Thanks @elisabethbik.bsky.social for your vigilance.

We are open to recruitment in Sheffield

The National Student Survey results are in and we're proud to say that we're top of the Russell Group for the third year in a row! And our Student's Union has been ranked number 1 once again. A testament to the hard work of our brilliant University community 👏🎉 sheffield.ac.uk/news/sheffie...

Proportion of NHS doctors who carry out research has fallen by a quarter over 13 years despite evidence suggesting hospitals with active research programmes deliver better patient outcomes, finds @policyatkings.bsky.social www.timeshighereducation.com/news/nhs-inn... via @helenpacker.bsky.social

Impressive poster from Dr Sophie Williams @sheffielduni.bsky.social on the microenvironment in GBM. Also her Supervisor @sdanson1.bsky.social #SMPHResearch&Innovation

This is superb news. Something to really celebrate. Thanks to all involved

Great work from Sophie Williams on brain ageing in the glioblastoma tumour microenvironment

Sheffield Ex Vivo Group out in force at Sheffield #smph_research&innovation meeting today. Callum Blee, Louis Lane and Jamie Adams pictured. Great to see

We are delighted to announce, along with Cancer Research UK (@cancerresearchuk.org), The University of Manchester (@manchester.ac.uk) and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Director! ⭐ Full story here: www.cruk.manchester.ac.uk/news/profess...

Enjoyed today. Looking forward to hearing more tomorrow

Christine Le Maitre opening our annual meeting #SMPH_Research&Innovation. Apologies I cannot rotate!!

Exciting opportunity to join the cancer research community in Sheffield!!

Huge congratulations, Jim

Yesterday, Professor Sarah Danson presented the results of the UK DANTE trial at the 2025 American Society of Clinical Oncology (ASCO) annual medical meeting. Read more: buff.ly/arneMoo #melanoma #melanomacancer #ASCO25

Honoured to present the DANTE trial at ASCO today on behalf of the extended DANTE team. Thank you to all the patients who were involved

Much less clarity on whether or not to continue systemic immunotherapy after pCR following neoadjuvant therapy The people have spoken, and they are undedecided - more work to do! #melsm #ASCO25

Great to meet up with Sheffield colleagues, Sophie Trotter and Syed Hussain at #ASCO25

Sophie Trotter at #ASCO25 presenting frailty measures from the STAR renal cell cancer trial @fohsheffield.bsky.social @sheffieldteachinghospitals @universityofleeds.bsky.social

Data from randomized Ph 3 trial that studied time of day of immunotherapy infusion said that infusion before 3:00 PM is far superior to > 3:00 PM. Study by Yongchang Zhang & team. Circadian rhythms with potential major impact on T cell circulation & exhaustion. h/t @stephenvliu.bsky.social #ASCO25

Phase II ipi nivo rela with IL6 inhibitor sarilumab with ORR 68% - highest reported with IO - and grade 3/4 irAEs 12% - lowest reported with combination IO Jan Mehnert @nyulangone.bsky.social #ASCO25 @ascocancer.bsky.social @aspire-cop.bsky.social

Melanoma rapid #3 ➡️ High fiber diet of 30-50g daily is tolerable, pCR 57% in neoadj group, grade 3+ irAE 28.8% Took 400 patients screened to enroll 45 🤔 Yiufan Qiu @mdanderson.bsky.social #ASCO25 @ascocancer.bsky.social @aspire-cop.bsky.social

Metastatic mucosal melanoma today: -combination immunotherapy shows lackluster efficacy -MEKi with 25% ORR -KIT + anti PD1 with 54.8% ORR -triplet ICI with 33% ORR -lenv pembro with 50% ORR -TIL with 50% ORR Jun Guo #ASCO25 #raremelanoma #rarecancers @ascocancer.bsky.social

This is fascinating. When paired with the Manchester abstract @beckilee.bsky.social and colleagues presented, do we need to change practice now?

Also please contact [email protected] for a sign up form so you can be kept up to date with CT RAD activities, meetings and opportunities @ctrad.bsky.social @icr.ac.uk @profemmahall.bsky.social @montefiored.bsky.social

News for UK radiotherapy community. Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad. We plan a proposals guidance meeting on 8.7.25 If you have a new trial idea and wish to attend please contact [email protected] to register

Well done @catrionamayland.bsky.social on this important work. Go Sheffield researchers @sheffielduni.bsky.social!

ONLINE Zoom Webinar Free to all UKONS members! This webinar will demystify the process behind the UKONS conference submission process with tips from previous winners. Chaired by: Dr Jo Bird, Research MIG Lead web-eur.cvent.com/event/4cdaed... #UKONSwebinar #Publication

📣Today marks the start of Melanoma Awareness Month 2025! There are a variety of ways that you can get involved throughout May 👉 buff.ly/3N8ELve Let’s reach as many people as possible and make a real difference.💙 #melanomaskincancer #melanomaawarenessmonth

☀️ Here are some worrying statistics that have come out of our recent public survey. Melanoma skin cancer rates continue to climb in the UK, the implications of these findings are significant. You can read more here 👉 buff.ly/6eT6MkF #MelanomaAwarenessmonth

May is Melanoma Awareness Month, a brilliant opportunity for us to come together to raise awareness of melanoma. Get prepared by downloading our communications toolkit👉https://buff.ly/BcV1bNi Let’s reach as many people as possible and make a real difference.💙 #melanoma

📣 BIG NEWS: £10 million in funding has been announced alongside @sheffielduni.bsky.social to help transform the prevention, diagnosis and treatment of cancer in Yorkshire. www.yorkshirecancerresearch.org.uk/news/groundb...

I am #hiring an #MRI #physicist, please consider making an application. The job is based in #Sheffield, with extensive collaboration with #UCL. Opportunity to work at 7T & 9.4T, & undertake human imaging at 3T in parallel with the core preclinincal work. jobsite.sheffield.ac.uk/job/Research...

Great time representing Research at the Sheffield Medical School Offer Holders Day

Congratulations to @prof-nick-james.bsky.social and the STAMPEDE clinical trial team @mrcctu.bsky.social on this prestigious @nihr.bsky.social award! 👏🥳 STAMPEDE has made such a huge difference to #ProstateCancer treatment around the world. #NIHRImpactPrizes

Great effort @dralexb.bsky.social

BTOG is excited to call for Trainee Representatives from the Oncology and Respiratory specialities to apply to the BTOG Steering Committee. #LCSM Full details: www.btog.org/call-for-tra...

🚨🚨JOB ALERT We’ve got a new job going developing AI algorithms for molecular classification of H&E images of ovarian cancer. Led by Elaine Leung you’ll get to learn cutting edge techniques and travel overseas More details here: edzz.fa.em3.oraclecloud.com/hcmUI/Candid...

Thank you to all the CNS teams. I am lucky to work with Janette

Note to anyone writing #clinicaltrial protocols: the word ‘subjects’ is pejorative and rude – people suffering illness may become patients of healthcare services, but transform themselves into participants when they volunteer to take part in clinical trials. Subjects are things we took at school.

National Cancer CNS Day day is on Friday 14th March. @ukons.bsky.social will be streaming videos as well get closer to the day which support and highlight this vital role. Check out the channel at youtube.com/playlist?lis...

Brilliant new paper from Jie Yang @jieyang437.bsky.social and Rahul Roychoudhuri @roychoudhurilab.bsky.social linking aspirin to immune-mediated prevention of cancer metastasis. www.nature.com/articles/s41...

We are recruiting a #postdoctoral researcher for our Cancer Inflammation and Immunity group headed by @santiagozelenay.bsky.social For all the project details, research background, information about the position and the Institute, please visit: www.cruk.manchester.ac.uk/career/mi-25...

We are top in the UK for attracting engineering research investment, bringing in £110 million in the past year - more than any other university in the country! So, where did that money come from? buff.ly/nl8crk8

Multi-cancer tests could signal to your GP if vague early-stage symptoms could be caused by cancer, potentially leading to earlier diagnosis when treatment is more likely to be successful. Explore how these tests work and how they could support GPs to diagnose cancer earlier 👇

Researchers at the University of Sheffield lead on an innovative pre-clinical project, funded by @cureparkinsons.org.uk, aimed at testing, evaluating, and comparing potential treatments that could slow the progression of Parkinson’s disease. 🧪🔍 www.sheffield.ac.uk/smph/news/re...

Big news from #BTOG25 … next year’s event will be held in the beautiful city of Edinburgh 4-6 March 2026.

“My mission is to spread the word that, just like pre-diabetes, there is such a thing as ‘pre’-cancer which is an untapped opportunity to intervene & save lives.” New @thelancet.bsky.social profile on Sarah Blagden, discussing what inspired her research on pre-cancer biology & preventive treatment:

How likely is it that a pt in a Phase 2 oncology trial will receive a drug that is ultimately FDA-approved? This study says 16.2% (19.4% for NCCN off-label recommendations as well). However, when using an ESMO scale assessing "substantial clinical benefit" it's 9.3% academic.oup.com/jnci/advance...